treatment of narcolepsy type 1
All entries for: Takeda Development Center Americas, Inc.
March 2, 2026
Takeda Development Center Americas, Inc.
Orphan Drug Designation
Cambridge
1-50 employees
Disease Area: Rare Disease
treatment of narcolepsy type 1